Your institution may have access to this item. Find your institution then sign in to continue.
Title
MacroGenics’ Margenza Access Support.
Abstract
The article discusses MacroGenics' Margenza Access Support program, providing assistance to patients and healthcare providers in accessing Margenza, a drug for metastatic HER2-positive breast cancer, offering services such as ordering information, reimbursement, and financial assistance programs.